Fennec Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FENC research report →
About the company
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate.
- CEO
- Jeffrey S. Hackman
- IPO
- 2017
- Employees
- 32
- HQ
- Research Triangle Park, NC, US
Price Chart
- Market Cap
- $305.81M
- P/E
- -34.84
- P/S
- 6.00
- P/B
- 9.75
- EV/EBITDA
- -39.81
- Div Yield
- 0.00%
- Gross Margin
- 92.23%
- Op Margin
- -11.04%
- Net Margin
- -16.42%
- ROE
- -54.75%
- ROIC
- -9.05%
- Revenue
- $44.64M · -6.09%
- Net Income
- $-9,741,000 · -2134.17%
- EPS
- $-0.36 · -2150.00%
- Op Income
- $-6,346,000
- FCF YoY
- -146.23%
- 52W High
- $11.31
- 52W Low
- $5.65
- 50D MA
- $8.76
- 200D MA
- $8.10
- Beta
- 1.08
- Avg Volume
- 271.23K
Get TickerSpark's AI analysis on FENC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Raykov Rosty | other | 15,597 |
| Jul 1, 26 | Raykov Rosty | other | 15,597 |
| Jul 1, 26 | Raykov Rosty | sell | 9,599 |
| Jul 1, 26 | Raykov Rosty | other | 2,778 |
| Jun 30, 26 | Evans Terry L | other | 168 |
| Jun 30, 26 | Sayad Pierre Sargis | other | 168 |
| Jun 30, 26 | Hackman Jeffrey S. | other | 1,159 |
| Jun 30, 26 | Andrade Robert | other | 1,703 |
| Jun 30, 26 | Cioffi Christiana Marie | other | 156 |
| Jun 10, 26 | Brughera Marco Maria | other | 20,000 |
Our FENC coverage
Recent articles, reports, and earnings notes.
No research on FENC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FENC report →Similar companies
Peers in the same neighborhood.